rs2854746

This is a protein-altering variant in the IGFBP3 gene.

GWAS Catalog Trait Associations (12)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

blood protein amount

Allele C
OR 0.53
p 2.0e-189
N 5,367
Large GWAS
European

nutritionally-regulated adipose and cardiac enriched protein homolog measurement

Pietzner M et al. Mapping the proteo-genomic convergence of human diseases. Science (new York, N.y.) 374(6569):eabj1541 (2021)
Allele C
OR 0.38
p 1.0e-182
N 10,708
Large GWAS
European

IGF-1 measurement

Allele C
OR 0.04
p 1.0e-104
N 394,642
Large GWAS
European

insulin-like growth factor-binding protein 3 measurement

Pietzner M et al. Mapping the proteo-genomic convergence of human diseases. Science (new York, N.y.) 374(6569):eabj1541 (2021)
Allele C
OR 0.23
p 8.0e-78
N 10,708
Large GWAS
European

IGFBP-3 measurement

Allele C
OR 0.40
p 1.0e-49
N 2,935
Large GWAS
Greater Middle Eastern (Middle Eastern, North African or Persian)

protein measurement

Pietzner M et al. Mapping the proteo-genomic convergence of human diseases. Science (new York, N.y.) 374(6569):eabj1541 (2021)
Allele C
OR 0.19
p 3.0e-48
N 10,708
Large GWAS
European

diastolic blood pressure

Allele C
OR 0.23
p 1.0e-19
N 459,777
Large GWAS
multi-ancestry

cortical thickness

van der Meer D et al. The genetic architecture of human cortical folding. Science Advances 7(51):eabj9446 (2021)
Allele C
OR 7.31
p 3.0e-13
N 33,748
Large GWAS
European

coronary artery calcification

Allele C
OR 0.11
p 5.0e-10
N 36,720
Large GWAS
multi-ancestry

body height

Allele G
OR 0.01
p 2.0e-9
N 405,540
Large GWAS
European

Research that mentions this SNP (5)

Insulin‐like growth factor pathway genes and blood concentrations, dietary protein and risk of prostate cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)
AssociationN=10,216Tsilidis KK et al.(2013)· International Journal of Cancer

This nested case-control study (5,253 cases, 4,963 controls) examined 16 SNPs in IGF pathway genes and their associations with prostate cancer risk, testing gene-environment interactions with dietary protein intake. Although the 16 SNPs were significantly associated with circulating IGF-1 or IGFBP-3 levels as expected, none were significantly associated with prostate cancer risk, and the SNP-protein interactions did not substantially differ by protein intake after multiple testing correction.

Traits studied:IGF-1 concentrationsIGFBP-3 concentrationsProstate cancer
Genes in the insulin and insulin-like growth factor pathway and odds of metachronous colorectal neoplasia
AssociationN=1,439Elizabeth C. LeRoy et al.(2011)· Human Genetics

This study analyzed 521 SNPs in 18 insulin and IGF pathway genes among 1,439 subjects from two chemoprevention trials to identify genetic interactions associated with metachronous colorectal neoplasia. Classification and regression tree (CART) analysis identified gene-by-gene interactions: carriers of the A allele at rs7166348 (IGF1R) with AA genotype at rs1823023 (PIK3R1) had the highest probability of adenoma (71.8%, OR 3.7; 95%CI 2.2-6.5), while those with A at rs7166348, G at rs1823023, and AA at rs10426094 (INSR) had the lowest risk (14.3%, OR 0.22; 95%CI 0.07-0.66). Multifactor dimensionality reduction identified a three-way interaction (rs7166348, rs12609995, rs2715425) with OR 2.12 (95%CI 1.70-2.65) for metachronous neoplasia.

Traits studied:Colorectal adenomaColorectal cancerMetachronous colorectal neoplasia
Genetic variation and circulating levels of IGF‐I and IGFBP‐3 in relation to risk of proliferative benign breast disease
AssociationN=718Xuefen Su et al.(2010)· International Journal of Cancer

This case-control study examined genetic variants in IGF-I, IGFBP-1, and IGFBP-3 genes in relation to proliferative benign breast disease (BBD) in 359 cases and 359 controls from the Nurses' Health Study II. Higher circulating IGFBP-3 levels were significantly associated with increased BBD risk (OR 1.70, p-trend = 0.03), while minor alleles of IGFBP-3 SNPs rs3110697 and rs2132570 were associated with significantly lower BBD risk (OR 0.6 and 0.2, p-trend = 0.02). Three other IGFBP-3 SNPs (rs2854744, rs2960436, rs2854746) were strongly associated with circulating IGFBP-3 levels.

Traits studied:Breast cancer riskProliferative benign breast disease
IGF1, IGFBP1, and IGFBP3 genes and mammographic density: The Multiethnic Cohort
AssociationN=819Martijn Verheus et al.(2010)· International Journal of Cancer

This study investigated the association between common genetic variation in IGF1, IGFBP1, and IGFBP3 genes and mammographic density in 819 women from the Multiethnic Cohort. Only weak evidence was found for associations: rs35767 (IGF1, p=0.03) was associated with 3.2% lower mammographic density, rs35539615 (IGFBP1, p=0.05) with higher density, and rs2453839 (IGFBP3, p=0.01) with lower density. Ethnicity significantly modified the associations for IGFBP3 variants.

Traits studied:Mammographic density
Altered transmission of HOX and apoptotic SNPs identify a potential common pathway for clubfoot
AssociationN=1,927Audrey R. Ester et al.(2009)· American Journal of Medical Genetics Part A

Family-based association study identifying altered transmission of SNPs in HOX gene clusters (HOXA, HOXD) and IGFBP3 as potential risk factors for clubfoot (talipes equinovarus), a common congenital limb defect. Key findings include significant associations with rs3801776 in HOXA (p=0.004 discovery, p=0.028 validation), rs13223993 in IGFBP3 (p=0.003), and strong gene-gene interactions between HOX and apoptotic pathway genes (CASP3, CASP10, Bid, Apaf1), suggesting HOX and apoptotic perturbations affect limb and muscle development.

Traits studied:Clubfoot (talipes equinovarus)Congenital vertical talusIdiopathic clubfoot

About IGFBP3

This gene is a member of the insulin-like growth factor binding protein (IGFBP) family and encodes a protein with an IGFBP domain and a thyroglobulin type-I domain. The protein forms a ternary complex with insulin-like growth factor acid-labile subunit (IGFALS) and either insulin-like growth factor (IGF) I or II. In this form, it circulates in the plasma, prolonging the half-life of IGFs and altering their interaction with cell surface receptors. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]

View all IGFBP3 variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…